Table 1 Patients’ general characteristics and clinical features
Patient No | Gender | Age | Weight (kg) | Antibody | Serum titer | CSF titer | MRI | EEG | Tumor |
|---|---|---|---|---|---|---|---|---|---|
1 | male | 30 | 50 | NMDAR | (+ +) | (+ +) | Abnormal signal in left occipital and temporal | Normal | None |
2 | male | 47 | 70 | NMDAR | (-) | (+ + +) | Abnormal signal in pedunculus cerebri, medulla oblongata | Abnormal | None |
3 | male | 16 | 70 | NMDAR | (+ + + +) | (+ + +) | Abnormal signal in left cerebellum and bilateral hippocampus | Abnormal | None |
4 | female | 28 | 52 | NMDAR | (+ + +) | (+ +) | Abnormal signal in bilateral frontoparietal and temporal lobe | Normal | Ovarian teratoma |
5 | female | 29 | 70 | NMDAR | (+ + +) | (+ +) | Normal | Abnormal | None |
6 | male | 51 | 71 | AMPAR | (+ +) | (+ +) | Abnormal signal in frontal lobe | Normal | None |
7 | male | 64 | 71 | GABA-BR | (+ + +) | (+ +) | Abnormal signal in hydrocephalus | Normal | None |
8 | female | 23 | 80 | NMDAR | ( +) | (+ +) | Abnormal signal in bilateral hippocampus | Abnormal | Ovarian teratoma |
9 | female | 16 | 38 | NMDAR | ( +) | (+ +) | Abnormal signal in left temporal lobe and hippocampus | Abnormal | None |
10 | male | 72 | 40 | GABA-BR | (+ + +) | (+ + +) | Multiple cerebral ischemia | Normal | esophagus cancer |
11 | male | 59 | 60 | NMDAR | (-) | (+ + +) | Normal | Abnormal | None |
12 | female | 19 | 40 | NMDAR | (+ + +) | (+ + +) | Normal | Abnormal | None |
13 | female | 16 | 50 | NMDAR | (+ + +) | (+ + +) | Intensified signal in bilateral pia mater | Abnormal | Ovarian teratoma |
14 | male | 66 | 65 | LGI1 | ( +) | ( +) | Abnormal signal in left hippocampus and frontal lobe | Normal | None |
15 | male | 59 | 61 | LGI1 | (+ +) | (-) | Abnormal signal in right frontal lobe | Abnormal | None |
16 | male | 64 | 60 | GABA-BR | (+ + +) | (+ + +) | Normal | Abnormal | Lung cancer |
17 | female | 21 | 45 | NMDAR | ( +) | (+ + +) | Abnormal signal in right frontal and parietal lobes | Abnormal | Ovarian teratoma |
18 | female | 28 | 56 | NMDAR | ( +) | (+ + +) | Abnormal signal in bilateral temporal lobe and basal ganglia region | Abnormal | Ovarian teratoma |
19 | male | 69 | 60 | LGI1 | (+ + +) | (+ + +) | Mesencephalon, bilateral basal ganglia region ischemia | Abnormal | none |
20 | male | 34 | 60 | NMDAR | (-) | (+ + +) | Normal | Abnormal | None |
21 | male | 45 | 90 | GABA-BR | (+ +) | (+ +) | Normal | Abnormal | Lung cancer |
22 | male | 56 | 66 | NMDAR | (-) | (+ +) | Bilateral hippocampus, front parietal and periventricular ischemia | Normal | None |
23 | female | 17 | 51 | NMDAR | (-) | (+ +) | Abnormal signal in left frontal lobe | Abnormal | None |
24 | male | 35 | 65 | NMDAR | ( +) | (+ +) | Abnormal signal in right temporal lobe, insular lobe and brainstem | Abnormal | None |
25 | male | 62 | 69 | AMPAR | (+ +) | (-) | Abnormal signal in bilateral hippocampus | Abnormal | Thymoma |
26 | male | 52 | 60 | GABA-BR | (+ +) | (+ +) | Abnormal signal in right temporal-parietal white matter | Abnormal | None |